Summary
NG Biotech is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develops a proprietary patented immunoassay platform for the development of quantitative and multiplex point of care diagnostics. NG Biotech’s immunoassay platform can be used to detect or monitor antibody, antigen, pathogen, parasite, hormone, drug, and others. The company provides product development, sample collection, assay calibration, optimization and validation, and integration services. Its products find applications in medical diagnostics, companion diagnostics, clinical trials, animal health diagnostics, OTC diagnostics, bio defense diagnostics, food and beverage testing, and agricultural and environmental testing. NG Biotech is headquartered in Rennes, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NG Biotech
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company